Age Related Macular Degeneration
Age Related Macular Degeneration
Age Related Macular Degeneration
Learning Outcomes
At the end of this tutorial, you will be able to:
Describe the basic epidemiology of ARMD as a major cause
of blindness
Explain the basic pathology that damages the retina in ARMD
Assess a patient presenting with ARMD, including taking a
relevant history and performing the appropriate examination
and investigations
Describe treatment regimens for ARMD and advise patients
on recognised preventative measures
The Retina
LIGHT
Retinal Transparency
Required for normal function
allows light through
Unmyelinated axons
Low density blood vessels
Blood retinal barriers
Loss of transparency
Haemorrhage
Oedema
Visual loss
Retinal Disease
Clinical assessment
History
VA
Amsler grid
Ophthalmoscopy
Retinal imaging
FFA
OCT
Age
Caucasian
Smoking
Diet
Symptoms
Distortion of vision
Central scotoma (blind spot)
Reading difficulties
Amsler grid
http://www.nei.nih.gov/health/maculardegen/armd_facts.asp
http://www.nei.nih.gov/health/maculardegen/armd_facts.asp
ARMD
Wet ARMD is more damaging to vision
2021
(000)
2026
(000)
5,687
6,068
28.1%
65-69
173.5
236.8
267.5
54.2%
70-74
130.8
201.8
224.8
71.9%
75-79
101.7
146.3
183.7
80.7%
80-84
70.3
95.6
123.6
75.8%
+85
60.4
94.3
118.6
96.3%
Age Group
% Change 2011/2026
ARMD
Pathology
Retinal pigment epithelial (RPE) cell loss
Drusen = deposits between RPE and photoreceptors
Photoreceptor loss
Dry ARMD
Drusen
Lipofuscin in RPE
Pigmentary changes
Mild visual impairment at this stage
Dry ARMD
Geographic atrophy
- leads to greater vision loss
- Develops slowly
Dry ARMD
Wet ARMD
Choroidal neovascular membrane
Haemorrhage
Oedema
Inflammation
Distortion
Central visual loss
Wet ARMD
Submacular haemorrhage
Macular exudates and oedema
- Indicate choroidal neovascular membrane
Wet ARMD
End-stage ARMD
Geographical atrophy
Scarring
Irreversible loss of central
vision
Submacular fibrosis
ARMD
Investigations
OCT
3D imaging
Retinal thickness
Fluid
Fluorescein Angiography
Leakage
hyperfluorescence
Treatment of ARMD
Early
Lifestyle changes stop
smoking
Diet
Exogenous antioxidants
Vitamins C, E
-Carotene
Zinc
Macular pigments
Lutein
Zeaxanthin
Treatment of ARMD
Wet ARMD
Intra-vitreal anti-VEGF therapy
Loading therapy x 3 months
Maintenance therapy
2/3 stabilise
1/3 improve
Treatment of ARMD
Dry ARMD
Low vision magnifying aids
Social services
Vitamin supplements unproven benefit
Learning Outcomes
At the end of this tutorial, you will be able to:
Describe the basic epidemiology of ARMD as a major cause
of blindness
Explain the basic pathology that damages the retina in ARMD
Assess a patient presenting with ARMD, including taking a
relevant history and performing the appropriate examination
and investigations
Describe treatment regimens for ARMD and advise patients
on recognised preventative measures